Dual-modality micro-positron emission tomography/computed tomography and near-infrared fluorescence imaging of EphB4 in orthotopic glioblastoma xenograft models

Molecular Imaging and Biology

Volumn 16, Issue 1, 2014, Pages 74-84

  Huang, Miao ^a   Xiong, Chiyi ^a   Lu, Wei ^b   Zhang, Rui ^a   Zhou, Min ^a   Huang, Qian ^a   Weinberg, Jeffrey ^a   Li, Chun ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

PET CT; EphB4; Near infrared; Optical imaging; Peptide

Indexed keywords

ANIMALS; AUTORADIOGRAPHY; BRAIN NEOPLASMS; CARBOCYANINES; CELL LINE, TUMOR; FLUORESCENCE; FLUORESCENT ANTIBODY TECHNIQUE; GLIOBLASTOMA; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; INFRARED RAYS; KINETICS; LUCIFERASES; MALE; MICE; MICE, NUDE; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY; RECEPTOR, EPHB4; SURFACE PLASMON RESONANCE; TISSUE DISTRIBUTION; TOMOGRAPHY, X-RAY COMPUTED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84895077478     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-013-0674-3     Document Type: Article

References (31)

1. Furnari FB, Fenton T, Bachoo RM et al (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21(2):683-710
2. Wen PY, Kesari S (2008) Malignant gliomas in adults. New Engl J Med 359:492-507
3. Murai KK, Pasquale EB (2003) 'Eph'ective signaling: forward, reverse and crosstalk. J Cell Sci 116:2823-2832
4. Flanagan JG, Vanderhaeghen P (1998) The ephrins and Eph receptors in neural development. Annu Rev Neurosci 21:309-345
5. Boyd AW, Lackmann M (2001) Signals from Eph and ephrin proteins: a developmental tool kit. Sci STKE 2001:re20
6. Holder N, Klein R (1999) Eph receptors and ephrins: effectors of morphogenesis. Development 126:2033-2044
7. Cheng N, Brantley DM, Chen J (2002) The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev 13:75-85
8. Durbin L, Brennan C, Shiomi K et al (1998) Eph signaling is required for segmentation and differentiation of the somites. Genes Dev 12:3096-3109
9. Pasquale EB, Deerinck TJ, Singer SJ, Ellisman MH (1992) Cek5, a membrane receptor-type tyrosine kinase, is in neurons of the embryonic and postnatal avian brain. J Neurosci 12:3956-3967
10. Dodelet VC, Pasquale EB (2000) Eph receptors and ephrin ligands: embryogenesis to tumorigenesis. Oncogene 19:5614-5619
11. Easty DJ, Herlyn M, Bennett DC (1995) Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis. Int J Cancer 60:129-136
12. Kiyokawa E, Takai S, Tanaka M et al (1994) Overexpression of ERK, an EPH family receptor protein tyrosine kinase, in various human tumors. Cancer Res 54:3645-3650
13. Wicks IP, Wilkinson D, Salvaris E, Boyd AW (1992) Molecular cloning of HEK, the gene encoding a receptor tyrosine kinase expressed by human lymphoid tumor cell lines. Proc Natl Acad Sci U S A 89:1611-1615
14. Erber R, Eichelsbacher U, Powajbo V et al (2006) EphB4 controls blood vascular morphogenesis during postnatal angiogenesis. EMBO J 25:628-641
15. Koolpe M, Burgess R, Dail M, Pasquale EB (2005) EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity. J Biol Chem 280:17301-17311
16. Kumar SR, Scehnet JS, Ley EJ et al (2009) Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression. Cancer Res 69:3736-3745
17. Kumar SR, Singh J, Xia G et al (2006) Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am J Pathol 169:279-293
18. Nakamoto M, Bergemann AD (2002) Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis. Microsc Res Tech 59:58-67
19. Pasquale EB (2005) EPH receptor signaling casts a wide net on cell behavior. Nat Rev Mol Cell Bio 6:462-475
20. Xia G, Kumar SP, Stein JP et al (2006) EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival. Oncogene 25:769-780
21. Xiong CY, Huang MA, Zhang R et al (2011) In vivo small-animal PET/CT of EphB4 receptors using Cu-64-labeled peptide. J Nucl Med 52:241-248
22. Zhang R, Xiong CY, Huang M et al (2011) Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenografts. Biomaterials 32:5872-5879
23. Wang W, Ke S, Kwon S et al (2007) A new optical and nuclear dual-labeled imaging agent targeting interleukin 11 receptor alpha-chain. Bioconjug Chem 18:397-402
24. Grinvald A, Frostig RD, Lieke E, Hildesheim R (1988) Optical imaging of neuronal activity. Physiol Rev 68:1285-1366
25. Gibson AP, Hebden JC, Arridge SR (2005) Recent advances in diffuse optical imaging. Phys Med Biol 50:R1-R43
26. Bremer C, Ntziachristos V, Weissleder R (2003) Optical-based molecular imaging: contrast agents and potential medical applications. Eur Radiol 13:231-243
27. Hielscher AH (2005) Optical tomographic imaging of small animals. Curr Opin Biotech 16:79-88
28. Licha K, Olbrich C (2005) Optical imaging in drug discovery and diagnostic applications. Adv Drug Deliv Rev 57:1087-1108
29. Niell CM, Smith SJ (2004) Live optical imaging of nervous system development. Annu Rev Physiol 66:771-798
30. 18F-FET PET) in glioblastoma surgery. Neurol Res 34:314-317
31. Stummer W, Pichlmeier U, Meinel T et al (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392-401